BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Talaie T, DiChiacchio L, Prasad NK, Pasrija C, Julliard W, Kaczorowski DJ, Zhao Y, Lau CL. Ischemia-reperfusion Injury in the Transplanted Lung: A Literature Review. Transplant Direct 2021;7:e652. [PMID: 33437867 DOI: 10.1097/TXD.0000000000001104] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Lin Z, Zhou J, Lin X, Wang Y, Zheng H, Huang W, Liu X, Li Y, Zhong N, Huang Y, Xu Y, Sang L. Reverse Trigger in Ventilated Non-ARDS Patients: A Phenomenon Can Not Be Ignored! Front Physiol 2021;12:670172. [PMID: 34393811 DOI: 10.3389/fphys.2021.670172] [Reference Citation Analysis]
2 Arni S, Maeyashiki T, Latshang T, Opitz I, Inci I. Ex Vivo Lung Perfusion with K(ATP) Channel Modulators Antagonize Ischemia Reperfusion Injury. Cells 2021;10:2296. [PMID: 34571948 DOI: 10.3390/cells10092296] [Reference Citation Analysis]
3 Mardomi A, Naderi SB, Vahed SZ, Ardalan M. New insights on the monitoring of solid-organ allografts based on immune cell signatures. Transpl Immunol 2021;70:101509. [PMID: 34843937 DOI: 10.1016/j.trim.2021.101509] [Reference Citation Analysis]
4 Chen-Yoshikawa TF. Ischemia-Reperfusion Injury in Lung Transplantation. Cells 2021;10:1333. [PMID: 34071255 DOI: 10.3390/cells10061333] [Reference Citation Analysis]
5 Van Slambrouck J, Van Raemdonck D, Vos R, Vanluyten C, Vanstapel A, Prisciandaro E, Willems L, Orlitová M, Kaes J, Jin X, Jansen Y, Verleden GM, Neyrinck AP, Vanaudenaerde BM, Ceulemans LJ. A Focused Review on Primary Graft Dysfunction after Clinical Lung Transplantation: A Multilevel Syndrome. Cells 2022;11:745. [PMID: 35203392 DOI: 10.3390/cells11040745] [Reference Citation Analysis]
6 Ding Y, Tu P, Chen Y, Huang Y, Pan X, Chen W. CYP2J2 and EETs protect against pulmonary arterial hypertension with lung ischemia-reperfusion injury in vivo and in vitro. Respir Res 2021;22:291. [PMID: 34774051 DOI: 10.1186/s12931-021-01891-w] [Reference Citation Analysis]
7 Shi Q, Feng N, Ma Q, Wang S, Zhang H, Huang D, Sun J, Shi M, Li T. ZNF354C Mediated by DNMT1 Ameliorates Lung Ischemia-Reperfusion Oxidative Stress Injury by Reducing TFPI Promoter Methylation to Upregulate TFPI. Oxidative Medicine and Cellular Longevity 2022;2022:1-18. [DOI: 10.1155/2022/7288729] [Reference Citation Analysis]
8 Forgie KA, Fialka N, Freed DH, Nagendran J. Lung Transplantation, Pulmonary Endothelial Inflammation, and Ex-Situ Lung Perfusion: A Review. Cells 2021;10:1417. [PMID: 34200413 DOI: 10.3390/cells10061417] [Reference Citation Analysis]
9 Ehrsam JP, Chen J, Rodriguez Cetina Biefer H, Opitz I, Arni S, Inci I. Ex Vivo Lung Perfusion with β-Nicotinamide Adenine Dinucleotide (NAD+) Improves Ischemic Lung Function. Antioxidants 2022;11:843. [DOI: 10.3390/antiox11050843] [Reference Citation Analysis]
10 Roesel MJ, Sharma NS, Schroeter A, Matsunaga T, Xiao Y, Zhou H, Tullius SG. Primary Graft Dysfunction: The Role of Aging in Lung Ischemia-Reperfusion Injury. Front Immunol 2022;13:891564. [PMID: 35686120 DOI: 10.3389/fimmu.2022.891564] [Reference Citation Analysis]